Green fluorescent-conjugated anti-CEA single chain antibody for the detection of CEA-positive cancer cells

Hybridoma

Volumn 30, Issue 3, 2011, Pages 229-238

  Salavatifar, Maryam ^a,b   Amin, Shadi ^a,b   Jahromi, Zahra Moghaddassi ^b   Rasgoo, Nasrin ^b   Rastgoo, Nasrin ^b   Arbabi, Mehdi ^b,c  

^a Khatam University   (Iran)

^b NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CHIMERIC PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; MONOCLONAL ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CANCER CELL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CARCINOEMBRYONIC ANTIGEN; CLONING, MOLECULAR; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GREEN FLUORESCENT PROTEINS; HUMANS; HYBRIDOMAS; IMMUNOTHERAPY; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEOPLASMS; SEQUENCE ANALYSIS, DNA; SINGLE-CHAIN ANTIBODIES; SPECTROMETRY, FLUORESCENCE; TUMOR MARKERS, BIOLOGICAL;

ESCHERICHIA COLI;

EID: 79959788974     PISSN: 15540014     EISSN: 15578348     Source Type: Journal    
DOI: 10.1089/hyb.2011.0009     Document Type: Article

References (61)

1. Friedman M, and Ståh S: Engineered affinity proteins for tumour-targeting applications. Biotechnol Appl Biochem 2009;53:1-29.
2. Wilkins DK, and Mayer A: Development of antibodies for cancer therapy. Expert Opin Biol Ther 2006;6:787-796. (Pubitemid 44418267)
3. Hudson PJ, and Souriau C: Engineered antibodies. Nat Med 2003;9:129-134. (Pubitemid 36098274)
4. Revets H, Baetselier PD, and Muyldermans S: Nanobodies as novel agents for cancer therapy. Expert Opin Biol Ther 2005;5(1):111-124. (Pubitemid 40116484)
5. Arbabi-Ghahroudi M, To R, Gaudette N, Hirama T, Ding W, MacKenzie R, and Tanha J: Aggregation-resistant VHs selected by in vitro evolution tend to have disulfide-bonded loops and acidic isoelectric points. Protein Eng Des Select 2009;22(2):59-66.
6. Malyankar UM: Tumor-associated antigens and biomarkers in cancer and immune therapy. Intl Rev Immunol 2007; 26(3&4):223-247. (Pubitemid 46900767)
7. Oren S, and Yoram R: Antibodies and their fragments as anti-cancer agents. Cancer Res 2006;66(7):3792-3801.
8. Zhao H, Cui K, Mmuschenborn A, and Wong STC: Progress of engineered antibody-targeted molecular imaging for solid tumor. Mol Med Rep 2008;1:131-134.
9. Harris M: Monoclonal antibodies as therapeutic agents for cancer. Lancet Oncol 2004;5(5):292-302. (Pubitemid 38541581)
10. Cao Y, and Suresh MR: Bispecific antibodies as novel bioconjugates. Bioconjugate Chem 1998;9:635-644. (Pubitemid 28542229)
11. Casey JL, Coley AM, Tilley LM, and Foley M: Green fluorescent antibodies: Novel in vitro tools. Protein Eng 2000; 13(6):445-452. (Pubitemid 30450105)
12. Chalfie M, Tu Y, Euskirchen G, Ward WW, and Prasher DC: Green fluorescent protein as a marker for gene expression. Science 1994;263(5148):802-805. (Pubitemid 24093206)
13. Skosyrev VS, Rudenko NV, Yakhnin AV, Zagranichny VE, Popova LI, Zakharov MV, Gorokhovatsky AY, and Vinokurov LM: EGFP as a fusion partner for the expression and organic extraction of small polypeptides. Protein Expr Purif 2003;27:55-62. (Pubitemid 37096470)
14. Cormack BP, Valdivia RH, and Falkow S: FACS-optimized mutants of the green fluorescent protein (GFP). Gene 1996; 173:33-38. (Pubitemid 26239677)
15. Feilmeier BJ, Iseminger G, Schroeder D, Webber H, and Phillips GJ: Green fluorescent protein functions as a reporter for protein localization in Escherichia coli. J Bacteriol 2000; 182(14):4068-4076. (Pubitemid 30436570)
16. Oelschlaeger P, Srikant-Iyer S, Lange S, Schmitt J, and Schmid RD: Fluorophor-linked immunosorbent assay: A time-and cost-saving method for the characterization of antibody fragments using a fusion protein of a single-chain antibody fragment and enhanced green fluorescent protein. Anal Biochem 2002;309:27-34. (Pubitemid 35305786)
17. Yi KS, Chung J, Park KH, Kim K, Im SY, Choi CY, Im MJ, and Kim UH: Expression system for enhanced green fluorescence protein conjugated recombinant antibody fragment. Hybridoma Hybridomics 2004;23(5):279-286. (Pubitemid 39431091)
18. Schwalbach G, Sibler AP, Choulier L, Deryckère F, and Weiss E: Production of fluorescent single-chain antibody fragments in Escherichia coli. Protein Expr Purif 2000;18(2): 121-132. (Pubitemid 30172217)
19. Petrausch U, Dernedde J, Coelho V, Panjideh H, Frey D, Fuchs H, Thiel E, and Deckert PM: A33scFv-green fluorescent protein, a recombinant single-chain fusion protein for tumor targeting. Protein Eng Des Select 2007;20(12):583-590.
20. Gold P, and Freedman SO: Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965;121: 439-462.
21. Ludwig JA, and Weinstein JN: Biomarkers in cancer staging, and treatment selection. Nat Rev Cancer 2005;5(11):845-856. (Pubitemid 41746029)
22. Yamashita K, and Watanabe M: Clinical significance of tumor markers and an emerging perspective on colorectal cancer. Cancer Sci 2009;100:195-199.
23. Schlom J: Basic principles and applications of monoclonal antibodies in the management of carcinomas. Cancer Res 1986;46:3225-3238.
24. Galfrè G, and Milstein C: Preparation of monoclonal antibodies: Strategies and procedures. Methods Enzymol 1981; 73:3-46.
25. Shulman M, Wilde CD, and Köhler G: A better cell line for making hybridomas secreting specific antibodies. Nature 1978;276(5685):269-270. (Pubitemid 9053903)
26. Friguet B, Chaffotte AF, Djavadi-Ohaniance L, and Goldberg ME: Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J Immunol Methods 1985;77(2):305-319. (Pubitemid 15103678)
27. Pope AR, Embleton MJ, and Mernaugh R: Construction and use of antibody gene repertoires. In: Antibody Engineering: A Practical Approach. McCafferty J, Hoogenboom HR, and Chiswell DJ (Eds). Oxford University Press, London, 1996, pp. 1-27.
28. McCafferty J, Hoogenboom HR, and Chiswell DJ: Antibody Engineering: A Practical Approach. Oxford University Press, London, 1996.
29. Sambrook J, Fritsch EF, and Maniatis T: Molecular Cloning: A Laboratory Manual, vols. 1-3. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
30. Skerra A, and Pluckthun A: Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 1988; 240(4855):1038-1041.
31. Mainville CA, Sheehan KM, Klaman LD, Giorgetti CA, Press JL, and Brodeur PH: Deletional mapping of fifteen mouse VH gene families reveals a common organization for three Igh haplotypes. J Immunol 1996;156(3):1038-1046.
32. Mak TW, and Simard JL: Handbook of Immune Response Genes. Plenum Press, New York, 1998, pp. 10-162.
33. Barbas CF III, Burton DR, Scott JK, and Silverman GJ: Phage Display: A Laboratory Manual. Cold Springs Harbor Laboratory Press, Cold Springs Harbor, New York, 2001.
34. Horton RM, Hunt HD, Ho SN, Pullen JK, and Pease LR: Engineering hybrid genes without the use of restriction enzymes: Gene splicing by overlap extension. Gene 1989;77:61-68. (Pubitemid 19125654)
35. Plucktun A: Antibodies from Escherichia coli. Nature 1990;347:497-498.
36. Kabat EA, Wu TT, Perry HM, Gottesman KS, and Foeller C: Sequences of Proteins of Immunological Interest, 5th ed. Bethesda, MD, National Institutes of Health, 1991.
37. Arruebo M, Valladares M, and González-Fernández A: Antibody-conjugated nanoparticles for biomedical applications. J Nanomaterials 2009, art. # 439389, 24 pages.
38. Robert JK, and Ira P: Immunotoxins in the treatment of hematologic malignancies. Curr Drug Targets 2006;7(10):1301-1311.
39. Schrama D, Reisfeld RA, and Becker JC: Antibody targeted drugs as cancer therapeutics. Nat Rev Drug Discov 2006; 5(2):147-159.
40. Teicher BA: Antibody-drug conjugate targets. Curr Cancer Drug Targets 2009;9(8):982-1004.
41. Shen Z, Pappan K, Mutti NS, He Q-J, Denton M, Zhang Y, Kanost MR, Reese JC, and Reeck GR: Pectinmethylesterase from the rice weevil, Sitophilus oryzae: CDNA isolation and sequencing, genetic origin, and expression of the recombinant enzyme. J Insect Sci 2005;5:21.
42. Horie M, Arai H, Noguchi S, Suzuki M, Sakamoto Y, and Oka T: Kartagener syndrome with lung cancer and mediastinal tumor. Nihon Kokyuki Gakkai Zasshi 2010;48(5):375-378.
43. Goldstein MJ, and Mitchell EP: Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest 2005;23:338-351. (Pubitemid 41656973)
44. Hammarström S: The carcinoembryonic antigen (CEA) family: Structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 1999;9(2): 67-81. (Pubitemid 29265523)
45. Khare PD, Shao-Xi L, Kuroki M, Hirose Y, Arakawa F, Nakamura K, Tomita Y, and Kuroki M: Specifically targeted killing of carcinoembryonic antigen (CEA)-expressing cells by a retroviral vector displaying single-chain variable fragmented antibody to CEA and carrying the gene for inducible nitric oxide synthase. Cancer Res 2001;61:370-375. (Pubitemid 32095740)
46. Kim JC, Koo KH, Kim BS, Park KC, Bicknell DC, and Bodmer WF: Carcino-embryonic antigen may function as a chemo-attractant in colorectal-carcinoma cell lines. Int J Cancer 1999;82(6):880-885. (Pubitemid 29384341)
47. Blumenthal RD, Hansen HJ, and Goldenberg DM: Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (carcinoembryonic antigen). Cancer Res 2005;65:8809-8817. (Pubitemid 41377369)
48. Wilkinson RW, Ross EL, Ellison D, Zimmermann W, Snary D, and Stephen J: Evaluation of a transgenic mouse model for anti-human CEA radioimmunotherapeutics. J Nucl Med 2002;43(10):1368-1376.
49. Wang D, Rayani S, and Marshall JL: Carcinoembryonic antigen as a vaccine target. Expert Rev Vaccines 2008;7(7):987-993.
50. Duffy MJ: Carcinoembryonic antigen as a marker for colorectal cancer. Clin Chem 2001;47:624-630. (Pubitemid 32275803)
51. Ilantzis C, DeMarte L, Screaton RA, and Stanners CP: Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation. Neoplasia 2002;4(2): 151-163. (Pubitemid 34218683)
52. Yamashita K, and Watanabe M: Clinical significance of tumor markers and an emerging perspective on colorectal cancer. Cancer Sci 2009;100(2):195-199.
53. Bird RE, Hardman KD, and Jacobson JW: Single-chain antigen-binding proteins. Science 1988;241(4877):423-426.
54. Wang HW, Cole D, Jiang WZ, Jin HT, N Fu, Chen ZL, and Jin NY: Engineering and functional evaluation of a singlechain antibody against HIV-1 external glycoprotein gp120. Clin Exp Immunol 2005;141(1):72-80. (Pubitemid 40904643)
55. Ettayebi K, and Hardy ME: Recombinant norovirus-specific scFv inhibit virus-like particle binding to cellular ligands. Virol J 2008;5:21.
56. Hudson PJ, and Kortt AA: High avidity scFv multimers; diabodies and triabodies. J Immunol Methods 1999;177-189. (Pubitemid 30394733)
57. Hink MA, Griep RA, Borst JW, Hoek AV, Eppink MH, Schots A, and Visser AJ: Structural dynamics of green fluorescent protein alone and fused with a single chain Fv protein. J Biol Chem 2000;275(23):17556-17560. (Pubitemid 30430798)
58. Kaushal S, McElroy MK, Luiken GA, Talamini MA, and Moossa AR: Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer. J Gastrointest Surg 2008;12:1938-1950.
59. Niswender KD, Blackman SM, Rohde L, Magnuson MA, and Piston DW: Quantitative imaging of green fluorescent protein in cultured cells: Comparison of microscopic techniques, use in fusion proteins and detection limits. J Microsc 1995;180:109-116.
60. Greiner JW, Guadagni F, Roselli M, Dansky Ullmann C, Nieroda C, and Schlom J: Improved experimental radioimmunotherapy of colon xenografts by combining I-CC49 and interferon-g. Cancer Res 1984;44:3208-3214.
61. Korn T, Nettelbeck DM, Völkel T, Müller R, and Kontermann RE: Recombinant bispecific antibodies for the targeting of adeno-viruses to CEA-expressing tumour cells: A comparative analysis of bacterially expressed single-chain diabody and tandem scFv. J Gene Med 2004;6:642-651. (Pubitemid 40228080)